355 related articles for article (PubMed ID: 33692755)
21. Identification of
Marques IJ; Gomes I; Pojo M; Pires C; Moura MM; Cabrera R; Santos C; van IJcken WFJ; Teixeira MR; Ramalho JS; Leite V; Cavaco BM
Thyroid; 2021 Sep; 31(9):1366-1375. PubMed ID: 33906393
[No Abstract] [Full Text] [Related]
22. Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer Risk.
Boonen RACM; Wiegant WW; Celosse N; Vroling B; Heijl S; Kote-Jarai Z; Mijuskovic M; Cristea S; Solleveld-Westerink N; van Wezel T; Beerenwinkel N; Eeles R; Devilee P; Vreeswijk MPG; Marra G; van Attikum H
Cancer Res; 2022 Feb; 82(4):615-631. PubMed ID: 34903604
[TBL] [Abstract][Full Text] [Related]
23. Functional characterization of CHEK2 variants in a Saccharomyces cerevisiae system.
Delimitsou A; Fostira F; Kalfakakou D; Apostolou P; Konstantopoulou I; Kroupis C; Papavassiliou AG; Kleibl Z; Stratikos E; Voutsinas GE; Yannoukakos D
Hum Mutat; 2019 May; 40(5):631-648. PubMed ID: 30851065
[TBL] [Abstract][Full Text] [Related]
24. Presumed Pathogenic Germ Line and Somatic Variants in African American Thyroid Cancer.
Hurst ZA; Liyanarachchi S; Brock P; He H; Nabhan F; Veloski C; Toland AE; Ringel MD; Jhiang SM
Thyroid; 2024 Mar; 34(3):378-387. PubMed ID: 38062767
[No Abstract] [Full Text] [Related]
25. The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma.
Bonora E; Rizzato C; Diquigiovanni C; Oudot-Mellakh T; Campa D; Vargiolu M; Guedj M; ; McKay JD; Romeo G; Canzian F; Lesueur F
Int J Cancer; 2014 May; 134(9):2098-107. PubMed ID: 24127282
[TBL] [Abstract][Full Text] [Related]
26. Variants in the ATM-CHEK2-BRCA1 axis determine genetic predisposition and clinical presentation of papillary thyroid carcinoma.
Wójcicka A; Czetwertyńska M; Świerniak M; Długosińska J; Maciąg M; Czajka A; Dymecka K; Kubiak A; Kot A; Płoski R; de la Chapelle A; Jażdżewski K
Genes Chromosomes Cancer; 2014 Jun; 53(6):516-23. PubMed ID: 24599715
[TBL] [Abstract][Full Text] [Related]
27. Genetic predisposition for nonmedullary thyroid cancer.
Nagy R; Ringel MD
Horm Cancer; 2015 Feb; 6(1):13-20. PubMed ID: 25338077
[TBL] [Abstract][Full Text] [Related]
28. CHEK2 mutations and the risk of papillary thyroid cancer.
Siołek M; Cybulski C; Gąsior-Perczak D; Kowalik A; Kozak-Klonowska B; Kowalska A; Chłopek M; Kluźniak W; Wokołorczyk D; Pałyga I; Walczyk A; Lizis-Kolus K; Sun P; Lubiński J; Narod SA; Góźdż S
Int J Cancer; 2015 Aug; 137(3):548-52. PubMed ID: 25583358
[TBL] [Abstract][Full Text] [Related]
29. Penetrance of a rare familial mutation predisposing to papillary thyroid cancer.
Saporito D; Brock P; Hampel H; Sipos J; Fernandez S; Liyanarachchi S; de la Chapelle A; Nagy R
Fam Cancer; 2018 Jul; 17(3):431-434. PubMed ID: 29027612
[TBL] [Abstract][Full Text] [Related]
30. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer.
Kim H; Cho DY; Choi DH; Oh M; Shin I; Park W; Huh SJ; Nam SJ; Lee JE; Kim SW
Breast Cancer Res Treat; 2017 Jan; 161(1):95-102. PubMed ID: 27783279
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the c.793-1G > A splicing variant in CHEK2 gene as pathogenic: a case report.
Agiannitopoulos K; Papadopoulou E; Tsaousis GN; Pepe G; Kampouri S; Kocdor MA; Nasioulas G
BMC Med Genet; 2019 Jul; 20(1):131. PubMed ID: 31349801
[TBL] [Abstract][Full Text] [Related]
32. First evidence of a large CHEK2 duplication involved in cancer predisposition in an Italian family with hereditary breast cancer.
Tedaldi G; Danesi R; Zampiga V; Tebaldi M; Bedei L; Zoli W; Amadori D; Falcini F; Calistri D
BMC Cancer; 2014 Jul; 14():478. PubMed ID: 24986639
[TBL] [Abstract][Full Text] [Related]
33. Acetylation dependent translocation of EWSR1 regulates CHK2 alternative splicing in response to DNA damage.
Zhang T; Wang Z; Liu M; Liu L; Yang X; Zhang Y; Bie J; Li Y; Ren M; Song C; Wang W; Tan H; Luo J
Oncogene; 2022 Jul; 41(29):3694-3704. PubMed ID: 35732801
[TBL] [Abstract][Full Text] [Related]
34. Mutant MYO1F alters the mitochondrial network and induces tumor proliferation in thyroid cancer.
Diquigiovanni C; Bergamini C; Evangelisti C; Isidori F; Vettori A; Tiso N; Argenton F; Costanzini A; Iommarini L; Anbunathan H; Pagotto U; Repaci A; Babbi G; Casadio R; Lenaz G; Rhoden KJ; Porcelli AM; Fato R; Bowcock A; Seri M; Romeo G; Bonora E
Int J Cancer; 2018 Oct; 143(7):1706-1719. PubMed ID: 29672841
[TBL] [Abstract][Full Text] [Related]
35. The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patients.
Wagener R; Walter C; Auer F; Alzoubi D; Hauer J; Fischer U; Varghese J; Dugas M; Borkhardt A; Brozou T
Int J Cancer; 2023 Apr; 152(7):1388-1398. PubMed ID: 36468172
[TBL] [Abstract][Full Text] [Related]
36. Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers.
Cirello V; Colombo C; Karapanou O; Pogliaghi G; Persani L; Fugazzola L
Front Endocrinol (Lausanne); 2020; 11():589340. PubMed ID: 33488516
[TBL] [Abstract][Full Text] [Related]
37. Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility.
Schutte M; Seal S; Barfoot R; Meijers-Heijboer H; Wasielewski M; Evans DG; Eccles D; Meijers C; Lohman F; Klijn J; van den Ouweland A; Futreal PA; Nathanson KL; Weber BL; Easton DF; Stratton MR; Rahman N;
Am J Hum Genet; 2003 Apr; 72(4):1023-8. PubMed ID: 12610780
[TBL] [Abstract][Full Text] [Related]
38. Identification of Novel Candidate Genes for Familial Thyroid Cancer by Whole Exome Sequencing.
Tous C; Muñoz-Redondo C; Bravo-Gil N; Gavilan A; Fernández RM; Antiñolo J; Navarro-González E; Antiñolo G; Borrego S
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175550
[TBL] [Abstract][Full Text] [Related]
39. Familial Aggregation and Heritability of Nonmedullary Thyroid Cancer in an Asian Population: A Nationwide Cohort Study.
Lin HT; Liu FC; Lin SF; Kuo CF; Chen YY; Yu HP
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32333767
[TBL] [Abstract][Full Text] [Related]
40. Response to DNA damage of CHEK2 missense mutations in familial breast cancer.
Roeb W; Higgins J; King MC
Hum Mol Genet; 2012 Jun; 21(12):2738-44. PubMed ID: 22419737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
